This is the authors' abstract. We don't add key points for this paper.
Antenatal corticosteroids are a well-established treatment for fetal lung maturation before 34 + 0 weeks of gestation. The administration of dexamethasone and betamethasone in late preterm - between 34 + 0 and 36 + 6 weeks of gestation - is still highly debated and subject of recent research. This topic was recently addressed by a retrospective observational cohort study aiming to investigate the benefits, short- and long-term risks of the application of antenatal corticosteroids in the late preterm phase. This commentary will discuss the main findings of the article and its implications for further research.
No takes yet. Share an insight, caveat, or question.
Jost et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: